← FDA DRUG APPROVALS

FDA ANDA · ANDA070317

CLONIDINE HYDROCHLORIDE

Sponsor: RISING

APPLICATION
ANDA070317
TYPE
ANDA
ORIGINAL APPROVAL
1987-06-09
LATEST ACTION
2013-01-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CLONIDINE HYDROCHLORIDEDiscontinued
CLONIDINE HYDROCHLORIDE 0.2MG · TABLET · ORAL
CLONIDINE HYDROCHLORIDEDiscontinued
CLONIDINE HYDROCHLORIDE 0.3MG · TABLET · ORAL
CLONIDINE HYDROCHLORIDEDiscontinued
CLONIDINE HYDROCHLORIDE 0.1MG · TABLET · ORAL

Approval history

2013-01-16Labeling · Supplement 23 · standardAP
1998-02-05Manufacturing (CMC) · Supplement 9AP
1997-07-15Labeling · Supplement 8AP
1995-02-24Manufacturing (CMC) · Supplement 7AP
1993-10-01Manufacturing (CMC) · Supplement 5AP
1991-07-29Manufacturing (CMC) · Supplement 1AP
1991-03-22Labeling · Supplement 4AP
1990-01-31Manufacturing (CMC) · Supplement 3AP
1987-06-09OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →